Bone marrow graft versus ALG in patients with aplastic anaemia
- PMID: 6357304
Bone marrow graft versus ALG in patients with aplastic anaemia
Abstract
Eighty-six successive patients with severe aplastic anaemia were admitted to this hospital between January 1976 and October 1982. They were treated and evaluated in a prospective study according to one protocol. 26 patients with an HLA identical sibling underwent bone marrow transplantation. Overall survival calculated according to Kaplan and Meier in this group is 47%, 60 patients without an HLA identical sibling were given antilymphocyte globulin with or without an infusion of HLA-haploidentical marrow. All these 60 patients received low dose androgens after the procedure. In this study the marrow infusion did not significantly improve the results and overall survival was 74% compared to 70% in patients receiving only antilymphocyte globulin and androgens. In a current pilot study combining ALG and high dose prednisone we were able to further increase remission rates. Between HLA-identical siblings we improved the results of marrow transplants significantly by the use of cyclosporin-A instead of methotrexate for prophylaxis against GvHD.
Similar articles
-
[Immunosuppression, bone marrow infusion and low dose androgens, successful therapy of severe aplastic anemia].Schweiz Med Wochenschr. 1979 Sep 29;109(37):1384-5. Schweiz Med Wochenschr. 1979. PMID: 384511 German.
-
[Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].Ned Tijdschr Geneeskd. 2002 Aug 17;146(33):1542-6. Ned Tijdschr Geneeskd. 2002. PMID: 12212502 Dutch.
-
Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.Bone Marrow Transplant. 1997 Jun;19(11):1085-7. doi: 10.1038/sj.bmt.1700795. Bone Marrow Transplant. 1997. PMID: 9193750
-
Treatment of aplastic anaemia by antilymphocyte globulin with or without marrow infusion.Clin Haematol. 1978 Oct;7(3):611-21. Clin Haematol. 1978. PMID: 31256 Review.
-
Treatment of acquired severe aplastic anemia.Am J Pediatr Hematol Oncol. 1989 Fall;11(3):360-7. Am J Pediatr Hematol Oncol. 1989. PMID: 2675662 Review.
Cited by
-
The release of interleukin-2 (IL-2) and colony stimulating activity (CSA) in aplastic anemia patients: opposite behaviour with improvement of bone marrow function.Blut. 1986 Apr;52(4):221-30. doi: 10.1007/BF00321081. Blut. 1986. PMID: 3486017
-
First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.PLoS One. 2011 Apr 25;6(4):e18572. doi: 10.1371/journal.pone.0018572. PLoS One. 2011. PMID: 21541024 Free PMC article.
-
Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody.Am J Pathol. 1985 Apr;119(1):1-4. Am J Pathol. 1985. PMID: 3885751 Free PMC article.
-
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2. Cochrane Database Syst Rev. 2013. PMID: 23881658 Free PMC article.
-
[Bone marrow transplantation in acute leukemia, chronic myeloid leukemia, severe aplastic anemia and stage IV neuroblastoma. Effect of antiviral prevention with anti-CMV-hyperimmunoglobulin and acyclovir].Klin Wochenschr. 1986 May 15;64(10):453-66. doi: 10.1007/BF01713171. Klin Wochenschr. 1986. PMID: 3014203 Free PMC article. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials